Dr. Harvey Risch of Yale School of Medicine- The Rise in Aggressive ’Turbo Cancers’ and Dr. Peter McCollough- Pull All COVID Jabs.

Dr. Harvey Risch of Yale School of Medicine- The Rise in Aggressive 'Turbo Cancers' and Dr. Peter McCollough- Pull All COVID Jabs.  

 

• Peter McCollough speaks to European Union Fatal COVID Vaccinations
• @P_McCulloughMD tells @EmeraldRobinson he backs calls to pull all Covid jabs off the European market
• Harvey Risch: Rise in Aggressive 'Turbo Cancers'–And Especially Among Younger People

 

Dr. Peter McCollough speaks to European Union Fatal COVID Vaccinations

Peter A. McCullough, MD, MPH™

@P_McCulloughMD

 

That's #courageousdiscourse! Great journalism!

@EmeraldRobinson

The Absolute Truth with @EmeraldRobinson

@AbsoluteWithE

Dr. Peter McCullough spoke in front of European Union to warn members about the fatal Covid jabs. @P_McCulloughMD tells @EmeraldRobinson he backs calls to pull all Covid jabs off the European market and to withdrawal from the corrupt World Health Organization.

 

Dr. Harvey Risch: Rise in Aggressive 'Turbo Cancers'–And Especially Among Younger People | ATL:NOW

American Thought Leaders

 

Views 135.1K •

September-11-2023

“What clinicians have been seeing,” says Dr. Harvey Risch, “is very strange things: For example, 25-year-olds with colon cancer, who don't have family histories of the disease—that's basically impossible along the known paradigm for how colon cancer works—and other long-latency cancers that they're seeing in very young people.”

Dr. Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. His research has focused extensively on the causes of cancer as well as prevention and early diagnosis.

We discuss the rise of what are called “turbo cancers” and what may be causing them.

“Some of these cancers are so aggressive that between the time that they're first seen and when they come back for treatment after a few weeks, they've grown dramatically compared to what oncologists would have expected for the way cancer normally progresses,” Dr. Risch says.